nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—TOP2A—adrenal gland cancer	0.92	1	CbGaD
Podofilox—CYP2C19—urine—adrenal gland cancer	0.00419	0.131	CbGeAlD
Podofilox—Teniposide—TOP2A—adrenal gland cancer	0.00392	0.455	CrCbGaD
Podofilox—NR3C1—urine—adrenal gland cancer	0.00328	0.103	CbGeAlD
Podofilox—Etoposide—TOP2A—adrenal gland cancer	0.00291	0.337	CrCbGaD
Podofilox—TUBA4A—adrenal cortex—adrenal gland cancer	0.00256	0.0801	CbGeAlD
Podofilox—CYP3A4—urine—adrenal gland cancer	0.00248	0.0776	CbGeAlD
Podofilox—TUBA4A—gonad—adrenal gland cancer	0.00212	0.0663	CbGeAlD
Podofilox—TUBA4A—cardiac atrium—adrenal gland cancer	0.00211	0.0662	CbGeAlD
Podofilox—TUBA4A—pituitary gland—adrenal gland cancer	0.00206	0.0647	CbGeAlD
Podofilox—TUBB—adrenal cortex—adrenal gland cancer	0.00187	0.0587	CbGeAlD
Podofilox—TUBA4A—adrenal gland—adrenal gland cancer	0.00184	0.0578	CbGeAlD
Podofilox—TUBB—cardiac atrium—adrenal gland cancer	0.00155	0.0485	CbGeAlD
Podofilox—NR3C1—Nuclear Receptors—NR5A1—adrenal gland cancer	0.00152	0.0386	CbGpPWpGaD
Podofilox—TUBB—pituitary gland—adrenal gland cancer	0.00151	0.0474	CbGeAlD
Podofilox—TOP2A—Circadian rythm related genes—SFPQ—adrenal gland cancer	0.00143	0.0362	CbGpPWpGaD
Podofilox—TOP2A—adrenal gland—adrenal gland cancer	0.00136	0.0427	CbGeAlD
Podofilox—TUBB—adrenal gland—adrenal gland cancer	0.00135	0.0424	CbGeAlD
Podofilox—TUBA4A—Loss of Nlp from mitotic centrosomes—PRKACA—adrenal gland cancer	0.00125	0.0318	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptor transcription pathway—NR5A1—adrenal gland cancer	0.0012	0.0305	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—SPARC—adrenal gland cancer	0.0012	0.0303	CbGpPWpGaD
Podofilox—TUBA4A—Pathogenic Escherichia coli infection—CDC42—adrenal gland cancer	0.00116	0.0293	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—SPARC—adrenal gland cancer	0.00114	0.0289	CbGpPWpGaD
Podofilox—TUBA4A—Centrosome maturation—PRKACA—adrenal gland cancer	0.00111	0.0282	CbGpPWpGaD
Podofilox—TUBB—Loss of Nlp from mitotic centrosomes—PRKACA—adrenal gland cancer	0.00107	0.027	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—RRM1—adrenal gland cancer	0.00103	0.0262	CbGpPWpGaD
Podofilox—TUBA4A—Regulation of PLK1 Activity at G2/M Transition—PRKACA—adrenal gland cancer	0.00102	0.0259	CbGpPWpGaD
Podofilox—TUBB—Pathogenic Escherichia coli infection—CDC42—adrenal gland cancer	0.000982	0.0249	CbGpPWpGaD
Podofilox—Etoposide—PTGS2—adrenal gland cancer	0.000972	0.113	CrCbGaD
Podofilox—TUBB—Centrosome maturation—PRKACA—adrenal gland cancer	0.000944	0.0239	CbGpPWpGaD
Podofilox—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—GNAS—adrenal gland cancer	0.000942	0.0239	CbGpPWpGaD
Podofilox—NR3C1—adrenal cortex—adrenal gland cancer	0.000868	0.0272	CbGeAlD
Podofilox—TUBB—Regulation of PLK1 Activity at G2/M Transition—PRKACA—adrenal gland cancer	0.000867	0.022	CbGpPWpGaD
Podofilox—Etoposide—ABCB1—adrenal gland cancer	0.000827	0.0959	CrCbGaD
Podofilox—TUBA4A—Platelet degranulation—IGF2—adrenal gland cancer	0.000825	0.0209	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—IGF2—adrenal gland cancer	0.000786	0.0199	CbGpPWpGaD
Podofilox—TUBA4A—G2/M Transition—PRKACA—adrenal gland cancer	0.000766	0.0194	CbGpPWpGaD
Podofilox—TUBA4A—Mitotic G2-G2/M phases—PRKACA—adrenal gland cancer	0.000755	0.0191	CbGpPWpGaD
Podofilox—NR3C1—gonad—adrenal gland cancer	0.000719	0.0225	CbGeAlD
Podofilox—NR3C1—cardiac atrium—adrenal gland cancer	0.000718	0.0225	CbGeAlD
Podofilox—NR3C1—pituitary gland—adrenal gland cancer	0.000701	0.022	CbGeAlD
Podofilox—TUBB—G2/M Transition—PRKACA—adrenal gland cancer	0.000651	0.0165	CbGpPWpGaD
Podofilox—TUBB—Mitotic G2-G2/M phases—PRKACA—adrenal gland cancer	0.000642	0.0163	CbGpPWpGaD
Podofilox—NR3C1—adrenal gland—adrenal gland cancer	0.000626	0.0196	CbGeAlD
Podofilox—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—adrenal gland cancer	0.000626	0.0159	CbGpPWpGaD
Podofilox—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.000611	0.0155	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000592	0.015	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.00055	0.014	CbGpPWpGaD
Podofilox—TUBA4A—Pathogenic Escherichia coli infection—CTNNB1—adrenal gland cancer	0.00053	0.0135	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—SPARC—adrenal gland cancer	0.00053	0.0135	CbGpPWpGaD
Podofilox—TOP2A—Gastric Cancer Network 2—CTNNB1—adrenal gland cancer	0.000499	0.0127	CbGpPWpGaD
Podofilox—TUBB—Pathogenic Escherichia coli infection—CTNNB1—adrenal gland cancer	0.000451	0.0114	CbGpPWpGaD
Podofilox—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—adrenal gland cancer	0.000428	0.0108	CbGpPWpGaD
Podofilox—TOP2A—Gastric Cancer Network 2—EGFR—adrenal gland cancer	0.000395	0.01	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—CDC42—adrenal gland cancer	0.00038	0.00963	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—IGF2—adrenal gland cancer	0.000366	0.00928	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—PRKACA—adrenal gland cancer	0.000361	0.00915	CbGpPWpGaD
Podofilox—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000335	0.0085	CbGpPWpGaD
Podofilox—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.000334	0.00848	CbGpPWpGaD
Podofilox—TOP2A—Gastric Cancer Network 2—TP53—adrenal gland cancer	0.000332	0.00842	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—REN—adrenal gland cancer	0.000297	0.00754	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.000297	0.00754	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	0.000277	0.00702	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SPARC—adrenal gland cancer	0.000273	0.00693	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TOP2A—adrenal gland cancer	0.000247	0.00627	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.000244	0.00618	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000238	0.00603	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	0.000235	0.00597	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PRKACA—adrenal gland cancer	0.000231	0.00585	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—PRKACA—adrenal gland cancer	0.000218	0.00552	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.000216	0.00547	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TOP2A—adrenal gland cancer	0.00021	0.00533	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—RB1—adrenal gland cancer	0.000209	0.0053	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.000208	0.00527	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.000207	0.00525	CbGpPWpGaD
Podofilox—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000202	0.00511	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—POMC—adrenal gland cancer	0.000197	0.00499	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—CDC42—adrenal gland cancer	0.000196	0.00496	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000192	0.00487	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CDKN2A—adrenal gland cancer	0.000191	0.00483	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IGF2—adrenal gland cancer	0.000189	0.00478	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—GNAS—adrenal gland cancer	0.000187	0.00474	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—PRKACA—adrenal gland cancer	0.000185	0.0047	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CDKN2A—adrenal gland cancer	0.000184	0.00466	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000177	0.00449	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—CTNNB1—adrenal gland cancer	0.000163	0.00414	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CTNNB1—adrenal gland cancer	0.000159	0.00404	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—IGF2—adrenal gland cancer	0.000148	0.00376	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TERT—adrenal gland cancer	0.000148	0.00376	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	0.000145	0.00369	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	0.000145	0.00367	CbGpPWpGaD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000139	0.00353	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—RB1—adrenal gland cancer	0.000132	0.00335	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.00013	0.0033	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—PRKACA—adrenal gland cancer	0.00013	0.00328	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.000129	0.00327	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.000128	0.00326	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TERT—adrenal gland cancer	0.000126	0.0032	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MED12—adrenal gland cancer	0.000125	0.00317	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.000119	0.00303	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	0.000117	0.00296	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—RB1—adrenal gland cancer	0.000115	0.00292	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	0.000113	0.00288	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000113	0.00286	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—RB1—adrenal gland cancer	0.00011	0.00278	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TP53—adrenal gland cancer	0.000106	0.00269	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDKN2A—adrenal gland cancer	0.000101	0.00257	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NR5A1—adrenal gland cancer	0.0001	0.00254	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—POMC—adrenal gland cancer	9.91e-05	0.00251	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—RB1—adrenal gland cancer	9.81e-05	0.00249	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—CTNNB1—adrenal gland cancer	9.72e-05	0.00246	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	9.64e-05	0.00244	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—adrenal gland cancer	9.34e-05	0.00237	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	9.23e-05	0.00234	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TERT—adrenal gland cancer	8.81e-05	0.00223	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDKN2A—adrenal gland cancer	8.62e-05	0.00219	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	8.4e-05	0.00213	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	8.36e-05	0.00212	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	7.75e-05	0.00197	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—RB1—adrenal gland cancer	7.67e-05	0.00195	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TP53—adrenal gland cancer	7.44e-05	0.00189	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CTNNB1—adrenal gland cancer	7.07e-05	0.00179	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—RB1—adrenal gland cancer	6.86e-05	0.00174	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	6.78e-05	0.00172	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	6.74e-05	0.00171	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CDKN2A—adrenal gland cancer	6.03e-05	0.00153	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MED12—adrenal gland cancer	6.01e-05	0.00152	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	5.99e-05	0.00152	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TP53—adrenal gland cancer	5.98e-05	0.00152	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	5.78e-05	0.00147	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MEN1—adrenal gland cancer	5.75e-05	0.00146	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—adrenal gland cancer	5.64e-05	0.00143	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SDHB—adrenal gland cancer	5.36e-05	0.00136	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—adrenal gland cancer	4.8e-05	0.00122	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	4.21e-05	0.00107	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	3.6e-05	0.000914	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—RRM1—adrenal gland cancer	3.45e-05	0.000875	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—SDHD—adrenal gland cancer	3.45e-05	0.000875	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—adrenal gland cancer	3.36e-05	0.000851	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SDHB—adrenal gland cancer	3.22e-05	0.000817	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MED12—adrenal gland cancer	2.57e-05	0.000653	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	2.3e-05	0.000583	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—RRM1—adrenal gland cancer	2.08e-05	0.000526	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—SDHD—adrenal gland cancer	2.08e-05	0.000526	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	1.88e-05	0.000476	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	1.83e-05	0.000465	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.55e-05	0.000392	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GNAS—adrenal gland cancer	1.52e-05	0.000386	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	1.49e-05	0.000379	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.13e-05	0.000286	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—POMC—adrenal gland cancer	1.02e-05	0.00026	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GNAS—adrenal gland cancer	9.15e-06	0.000232	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	8.98e-06	0.000228	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	8.17e-06	0.000207	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—POMC—adrenal gland cancer	6.16e-06	0.000156	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	4.91e-06	0.000125	CbGpPWpGaD
